MPM Oncology Impact Management GP LLC
Insider CIK 1721035 · SNSS 10% owner · ONCR 10% owner · HARP 10% owner · TCRR 10% owner · HOWL 10% owner · CGEM 10% owner · ITOS 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CGEM Cullinan Oncology, Inc. | S Sale | 2021-08-25 | 2021-08-25 | 1,713 | $29.09 | $49.8K | 7,805,483 | SEC↗ |
| CGEM Cullinan Oncology, Inc. | S Sale | 2021-08-24 | 2021-08-25 | 50,822 | $29.48 | $1.50M | 7,807,196 | SEC↗ |
| CGEM Cullinan Oncology, Inc. | S Sale | 2021-08-23 | 2021-08-25 | 53,359 | $29.11 | $1.55M | 7,858,018 | SEC↗ |
| CGEM Cullinan Oncology, Inc. | S Sale | 2021-08-11 | 2021-08-12 | 2,510 | $29.05 | $72.9K | 7,911,377 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-06-02 | 2021-06-02 | 25,118 | $20.50 | $514.9K | 6,328,095 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-06-01 | 2021-06-02 | 18,491 | $20.44 | $378.0K | 6,353,213 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-05-28 | 2021-06-02 | 100 | $22.60 | $2.3K | 6,371,704 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-05-28 | 2021-06-02 | 3,100 | $21.92 | $68.0K | 6,371,804 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-05-28 | 2021-06-02 | 10,685 | $20.88 | $223.1K | 6,374,904 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-05-27 | 2021-05-27 | 13,961 | $20.26 | $282.8K | 6,385,589 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-05-26 | 2021-05-27 | 3,198 | $20.04 | $64.1K | 6,399,550 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-05-24 | 2021-05-24 | 5,000 | $20.12 | $100.6K | 6,402,748 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-05-21 | 2021-05-24 | 10,907 | $20.21 | $220.4K | 6,407,748 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-05-20 | 2021-05-20 | 11,713 | $20.34 | $238.2K | 6,418,655 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-05-19 | 2021-05-20 | 17,833 | $20.39 | $363.6K | 6,430,368 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-05-18 | 2021-05-20 | 18,402 | $20.67 | $380.4K | 6,448,201 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-05-17 | 2021-05-17 | 4,666 | $20.07 | $93.6K | 6,466,603 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-05-14 | 2021-05-17 | 6,900 | $20.04 | $138.3K | 6,471,269 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-05-13 | 2021-05-17 | 4,855 | $20.06 | $97.4K | 6,478,169 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-05-12 | 2021-05-12 | 29,684 | $20.53 | $609.4K | 6,483,024 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-05-11 | 2021-05-12 | 7,672 | $21.51 | $165.0K | 6,512,708 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-05-11 | 2021-05-12 | 13,773 | $20.96 | $288.7K | 6,520,380 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-05-10 | 2021-05-12 | 16,722 | $21.78 | $364.2K | 6,534,564 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-05-10 | 2021-05-12 | 411 | $22.46 | $9.2K | 6,534,153 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-05-05 | 2021-05-06 | 59 | $23.09 | $1.4K | 6,551,286 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-05-05 | 2021-05-06 | 10,113 | $22.52 | $227.7K | 6,551,345 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | C Conversion deriv | 2021-05-04 | 2021-05-06 | 38,817,998 | — | $0 | 0 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | C Conversion deriv | 2021-05-04 | 2021-05-06 | 12,899,925 | — | $0 | 0 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-05-04 | 2021-05-04 | 26,230 | $23.03 | $604.1K | 6,564,958 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-05-04 | 2021-05-04 | 3,500 | $23.33 | $81.7K | 6,561,458 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | P Buy | 2021-05-04 | 2021-05-06 | 245,000 | $16.00 | $3.92M | 6,672,183 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | C Conversion | 2021-05-04 | 2021-05-06 | 1,488,033 | — | $0 | 6,427,183 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | C Conversion | 2021-05-04 | 2021-05-06 | 4,477,742 | — | $0 | 4,939,150 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-05-03 | 2021-05-04 | 4,401 | $23.45 | $103.2K | 6,591,188 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-05-03 | 2021-05-04 | 26,365 | $23.03 | $607.2K | 6,595,589 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-04-30 | 2021-05-04 | 268,023 | $22.35 | $5.99M | 6,621,954 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-04-29 | 2021-04-29 | 45,511 | $22.02 | $1.00M | 6,911,758 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-04-29 | 2021-04-29 | 21,781 | $22.54 | $490.9K | 6,889,977 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-04-28 | 2021-04-29 | 14,219 | $21.64 | $307.7K | 6,994,072 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-04-28 | 2021-04-29 | 36,803 | $22.01 | $810.0K | 6,957,269 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-04-27 | 2021-04-29 | 8,328 | $21.26 | $177.1K | 7,008,291 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-04-27 | 2021-04-29 | 3,501 | $20.99 | $73.5K | 7,016,619 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-04-21 | 2021-04-22 | 555 | $19.48 | $10.8K | 7,020,120 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-04-21 | 2021-04-22 | 8,417 | $18.94 | $159.4K | 7,020,675 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-04-20 | 2021-04-20 | 834 | $19.09 | $15.9K | 7,029,092 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-04-20 | 2021-04-20 | 21,415 | $18.70 | $400.5K | 7,029,926 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-04-19 | 2021-04-20 | 9,956 | $19.29 | $192.1K | 7,051,441 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-04-19 | 2021-04-20 | 100 | $20.08 | $2.0K | 7,051,341 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-04-16 | 2021-04-20 | 300 | $20.56 | $6.2K | 7,061,397 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-04-16 | 2021-04-20 | 5,547 | $19.82 | $109.9K | 7,061,697 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-04-15 | 2021-04-15 | 8,696 | $20.49 | $178.2K | 7,067,244 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-04-14 | 2021-04-15 | 12,806 | $20.83 | $266.7K | 7,075,940 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-04-14 | 2021-04-15 | 1,000 | $20.06 | $20.1K | 7,088,746 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-04-13 | 2021-04-15 | 13,692 | $19.35 | $264.9K | 7,092,108 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-04-13 | 2021-04-15 | 2,362 | $20.08 | $47.4K | 7,089,746 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-04-12 | 2021-04-13 | 13,528 | $20.72 | $280.3K | 7,112,900 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-04-12 | 2021-04-13 | 6,700 | $21.52 | $144.2K | 7,106,200 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-04-12 | 2021-04-13 | 400 | $22.68 | $9.1K | 7,105,800 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-04-09 | 2021-04-13 | 10,300 | $23.67 | $243.8K | 7,126,428 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-04-09 | 2021-04-13 | 200 | $29.99 | $6.0K | 6,004,368 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-04-08 | 2021-04-09 | 31,890 | $30.51 | $973.0K | 6,004,982 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-04-08 | 2021-04-09 | 414 | $31.01 | $12.8K | 6,004,568 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-04-07 | 2021-04-09 | 1,300 | $33.84 | $44.0K | 6,052,542 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | J Other | 2021-04-07 | 2021-04-09 | 15,670 | — | $0 | 6,036,872 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-04-07 | 2021-04-09 | 3,083 | $32.84 | $101.2K | 6,053,842 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-04-07 | 2021-04-09 | 5,295 | $32.07 | $169.8K | 6,056,925 | SEC↗ |
| CGEM Cullinan Management, Inc. | C Conversion deriv | 2021-01-12 | 2021-01-14 | 2,276,692 | — | $0 | 0 | SEC↗ |
| CGEM Cullinan Management, Inc. | C Conversion deriv | 2021-01-12 | 2021-01-14 | 649,030 | — | $0 | 0 | SEC↗ |
| CGEM Cullinan Management, Inc. | C Conversion deriv | 2021-01-12 | 2021-01-14 | 1,136,525 | — | $0 | 0 | SEC↗ |
| CGEM Cullinan Management, Inc. | C Conversion deriv | 2021-01-12 | 2021-01-14 | 3,551,640 | — | $0 | 0 | SEC↗ |
| CGEM Cullinan Management, Inc. | P Buy | 2021-01-12 | 2021-01-14 | 300,000 | $21.00 | $6.30M | 7,913,887 | SEC↗ |
| CGEM Cullinan Management, Inc. | C Conversion | 2021-01-12 | 2021-01-14 | 649,030 | — | $0 | 7,613,887 | SEC↗ |
| CGEM Cullinan Management, Inc. | C Conversion | 2021-01-12 | 2021-01-14 | 1,136,525 | — | $0 | 1,136,525 | SEC↗ |
| CGEM Cullinan Management, Inc. | C Conversion | 2021-01-12 | 2021-01-14 | 3,551,640 | — | $0 | 4,688,165 | SEC↗ |
| CGEM Cullinan Management, Inc. | C Conversion | 2021-01-12 | 2021-01-14 | 2,276,692 | — | $0 | 6,964,857 | SEC↗ |
| ONCR Oncorus, Inc. | C Conversion deriv | 2020-10-06 | 2020-10-08 | 1,525,348 | — | $0 | 0 | SEC↗ |
| ONCR Oncorus, Inc. | C Conversion deriv | 2020-10-06 | 2020-10-08 | 700,453 | — | $0 | 0 | SEC↗ |
| ONCR Oncorus, Inc. | C Conversion | 2020-10-06 | 2020-10-08 | 700,453 | — | $0 | 2,225,801 | SEC↗ |
| ONCR Oncorus, Inc. | P Buy | 2020-10-06 | 2020-10-08 | 151,224 | $15.00 | $2.27M | 2,377,025 | SEC↗ |
| ONCR Oncorus, Inc. | C Conversion | 2020-10-06 | 2020-10-08 | 1,525,348 | — | $0 | 1,525,348 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion deriv | 2020-07-28 | 2020-07-30 | 4,211,330 | — | $0 | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion deriv | 2020-07-28 | 2020-07-30 | 3,824,591 | — | $0 | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion deriv | 2020-07-28 | 2020-07-30 | 255,094 | — | $0 | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion deriv | 2020-07-28 | 2020-07-30 | 131,645 | — | $0 | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion deriv | 2020-07-28 | 2020-07-30 | 2,600,628 | — | $0 | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion deriv | 2020-07-28 | 2020-07-30 | 29,440 | — | $0 | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion deriv | 2020-07-28 | 2020-07-30 | 79,281 | — | $0 | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion deriv | 2020-07-28 | 2020-07-30 | 1,491,666 | — | $0 | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion deriv | 2020-07-28 | 2020-07-30 | 81,295 | — | $0 | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion deriv | 2020-07-28 | 2020-07-30 | 157,529 | — | $0 | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion deriv | 2020-07-28 | 2020-07-30 | 2,361,805 | — | $0 | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion deriv | 2020-07-28 | 2020-07-30 | 47,674 | — | $0 | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion deriv | 2020-07-28 | 2020-07-30 | 128,384 | — | $0 | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion deriv | 2020-07-28 | 2020-07-30 | 2,415,530 | — | $0 | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | P Buy | 2020-07-28 | 2020-07-30 | 1,121 | $19.00 | $21.3K | 25,974 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | P Buy | 2020-07-28 | 2020-07-30 | 56,814 | $19.00 | $1.08M | 1,316,139 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion | 2020-07-28 | 2020-07-30 | 24,326 | — | $0 | 66,931 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion | 2020-07-28 | 2020-07-30 | 457,706 | — | $0 | 1,259,325 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion | 2020-07-28 | 2020-07-30 | 24,944 | — | $0 | 68,381 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion | 2020-07-28 | 2020-07-30 | 48,336 | — | $0 | 132,991 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion | 2020-07-28 | 2020-07-30 | 724,702 | — | $0 | 1,993,932 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion | 2020-07-28 | 2020-07-30 | 1,397,574 | — | $0 | 1,397,574 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion | 2020-07-28 | 2020-07-30 | 15,820 | — | $0 | 15,820 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion | 2020-07-28 | 2020-07-30 | 42,605 | — | $0 | 42,605 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion | 2020-07-28 | 2020-07-30 | 801,619 | — | $0 | 801,619 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion | 2020-07-28 | 2020-07-30 | 43,687 | — | $0 | 43,687 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion | 2020-07-28 | 2020-07-30 | 9,033 | — | $0 | 24,853 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion | 2020-07-28 | 2020-07-30 | 797,983 | — | $0 | 2,195,557 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | P Buy | 2020-07-28 | 2020-07-30 | 89,955 | $19.00 | $1.71M | 2,083,887 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | P Buy | 2020-07-28 | 2020-07-30 | 5,994 | $19.00 | $113.9K | 138,985 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion | 2020-07-28 | 2020-07-30 | 84,655 | — | $0 | 84,655 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion | 2020-07-28 | 2020-07-30 | 1,269,230 | — | $0 | 1,269,230 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | P Buy | 2020-07-28 | 2020-07-30 | 160,000 | $19.00 | $3.04M | 2,355,557 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | P Buy | 2020-07-28 | 2020-07-30 | 3,096 | $19.00 | $58.8K | 71,727 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | P Buy | 2020-07-28 | 2020-07-30 | 3,020 | $19.00 | $57.4K | 69,951 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | C Conversion deriv | 2019-02-19 | 2019-02-21 | 15,000,000 | — | $0 | 0 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | C Conversion deriv | 2019-02-19 | 2019-02-21 | 1,750,000 | — | $0 | 0 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | C Conversion | 2019-02-19 | 2019-02-21 | 2,421,775 | — | $0 | 2,421,775 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | C Conversion | 2019-02-19 | 2019-02-21 | 282,540 | — | $0 | 2,704,315 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | P Buy | 2019-02-19 | 2019-02-21 | 666,667 | $15.00 | $10.00M | 3,370,982 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | C Conversion deriv | 2019-02-12 | 2019-02-14 | 417,853 | — | $0 | 0 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | C Conversion deriv | 2019-02-12 | 2019-02-14 | 1,525,165 | — | $0 | 0 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | X Exercise deriv | 2019-02-12 | 2019-02-14 | 76,258 | — | $0 | 0 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | C Conversion deriv | 2019-02-12 | 2019-02-14 | 1,578,755 | — | $0 | 0 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | X Exercise deriv | 2019-02-12 | 2019-02-14 | 50,838 | — | $0 | 0 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | C Conversion | 2019-02-12 | 2019-02-14 | 1,525,165 | — | $0 | 1,525,165 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | C Conversion | 2019-02-12 | 2019-02-14 | 1,578,755 | — | $0 | 3,103,920 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | C Conversion | 2019-02-12 | 2019-02-14 | 417,853 | — | $0 | 3,521,773 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | X Exercise | 2019-02-12 | 2019-02-14 | 127,096 | $0.05 | $6.4K | 3,648,869 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2019-02-12 | 2019-02-14 | 447 | $14.00 | $6.3K | 3,648,422 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | P Buy | 2019-02-12 | 2019-02-14 | 250,000 | $14.00 | $3.50M | 3,898,422 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | P Buy | 2017-11-06 | 2017-11-06 | 16,200 | $2.77 | $44.9K | 3,331,500 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | P Buy | 2017-11-03 | 2017-11-06 | 40,000 | $2.89 | $115.6K | 3,315,300 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | P Buy | 2017-11-02 | 2017-11-06 | 25,300 | $2.59 | $65.5K | 3,275,300 | SEC↗ |